Shandong Sito Bio-technology Co Ltd Total Liabilities

Latest as of June 2026: CN¥1.16 Billion CNY ≈ $169.59 Million USD

Shandong Sito Bio-technology Co Ltd total liabilities. Based on the latest financial reports, Shandong Sito Bio-technology Co Ltd (300583) has total liabilities worth CN¥1.16 Billion CNY (≈ $169.59 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of Shandong Sito Bio-technology Co Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Shandong Sito Bio-technology Co Ltd (2012–2025)

Total liabilities of Shandong Sito Bio-technology Co Ltd from 2012 to 2025. This chart illustrates how Shandong Sito Bio-technology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Shandong Sito Bio-technology Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.

Shandong Sito Bio-technology Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shandong Sito Bio-technology Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Gogo Inc
NASDAQ:GOGO
USA $1.12 Billion
Palmer Square Capital BDC Inc.
NYSE:PSBD
USA $726.43 Billion
Planet Technology
TWO:6263
Taiwan NT$996.26 Million
Rana Gruber AS
OL:RANA
Norway Nkr783.91 Million
Yaxing Chem
SHG:600319
China CN¥2.64 Billion
Shenke Slide Bearing Corp
SHE:002633
China CN¥374.40 Million
Blend Labs Inc
NYSE:BLND
USA $217.17 Million
Transcontinental Inc
TO:TCL-A
Canada CA$815.10 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Shandong Sito Bio-technology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Shandong Sito Bio-technology Co Ltd (300583) total assets.

Liquidity & Leverage Metrics

Shandong Sito Bio-technology Co Ltd Total Liabilities Ratios Explained

Shandong Sito Bio-technology Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 1.26 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.66 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.39 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shandong Sito Bio-technology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shandong Sito Bio-technology Co Ltd (2012–2025)

The table below shows the annual total liabilities of Shandong Sito Bio-technology Co Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥1.16 Billion
≈ $169.59 Million
+1.52%
2024-12-31 CN¥1.14 Billion
≈ $167.06 Million
-2.82%
2023-12-31 CN¥1.17 Billion
≈ $171.91 Million
-4.04%
2022-12-31 CN¥1.22 Billion
≈ $179.15 Million
-1.09%
2021-12-31 CN¥1.24 Billion
≈ $181.11 Million
+7.63%
2020-12-31 CN¥1.15 Billion
≈ $168.27 Million
+4.49%
2019-12-31 CN¥1.10 Billion
≈ $161.04 Million
+50.21%
2018-12-31 CN¥732.63 Million
≈ $107.21 Million
+130.81%
2017-12-31 CN¥317.42 Million
≈ $46.45 Million
-4.74%
2016-12-31 CN¥333.22 Million
≈ $48.76 Million
+0.48%
2015-12-31 CN¥331.62 Million
≈ $48.53 Million
+53.30%
2014-12-31 CN¥216.31 Million
≈ $31.65 Million
+93.44%
2013-12-31 CN¥111.83 Million
≈ $16.36 Million
+306.45%
2012-12-31 CN¥27.51 Million
≈ $4.03 Million
--

About Shandong Sito Bio-technology Co Ltd

SHE:300583 China Biotechnology
Market Cap
$305.91 Million
CN¥2.09 Billion CNY
Market Cap Rank
#14460 Global
#4265 in China
Share Price
CN¥11.02
Change (1 day)
+2.32%
52-Week Range
CN¥10.77 - CN¥16.07
All Time High
CN¥50.68
About

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9a-hydroxyandrost, 17a-hydroxyprogesterone, 17a-hydroxy progesterone derivatives, anecort acetate, bis-decyl alcohol (BA), neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, 16ß and 16… Read more